UBS’s Advantest Corp ATE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2014
Q3
$5K Sell
385
-2,146
-85% -$25.6K ﹤0.01% 9549
2014
Q2
$31K Buy
2,531
+231
+10% +$2.63K ﹤0.01% 7532
2014
Q1
$25K Buy
+2,300
New +$25.1K ﹤0.01% 7821
2013
Q4
Sell
-331
Closed -$4K 11107
2013
Q3
$4K Sell
331
-52
-14% -$710 ﹤0.01% 9654
2013
Q2
$6K Buy
+383
New +$5.92K ﹤0.01% 9172

Other funds holding ATE

UBS's ATE Position: Q3 2014 in Review

UBS reduced its Advantest Corp (ATE) stake by 85% in Q3 2014, selling an estimated $25.6K and leaving 385 shares worth $5K. The position accounts for ﹤0.01% of the portfolio, ranked #9549.

UBS first reported a position in ATE in Q2 2013 and has held it in 5 quarters since. The position peaked at $31K in Q2 2014. 22 funds tracked by Wall St. Rank hold ATE as of Q3 2014.

  • UBS held 385 shares of Advantest Corp worth $5K as of Q3 2014.
  • UBS sold 2,146 Advantest Corp shares in Q3 2014, an estimated $25.6K.
  • Advantest Corp made up ﹤0.01% of UBS's portfolio in Q3 2014, its #9549 holding.
  • UBS first reported a position in Advantest Corp in Q2 2013 and has held it in 5 quarters since.
  • UBS's Advantest Corp position peaked at $31K in Q2 2014.
  • 22 funds tracked by Wall St. Rank held Advantest Corp as of Q3 2014.

Based on UBS's 13F filing for Q3 2014, filed 12 Nov 2014.